Le Lézard
Classified in: Health
Subject: VET

Actify Announces Launch of Innovative Treatment for Veterans Living with PTSD and Mental Health Issues


BALTIMORE, Aug. 20, 2019 /PRNewswire/ -- Actify, a leader in innovative mental health treatment, is proud to support veteran care with the launch of Transcranial Magnetic Stimulation (TMS) in the State of Maryland. With the addition of TMS to the Baltimore and Potomac office locations, Actify is becoming a care provider within the TRICARE East military insurance network, making mental healthcare treatment more easily accessible for veterans.

TMS is FDA-approved for treatment resistant depression, but may also be delivered off-label for OCD, PTSD, and anxiety; all common mental health issues that veterans face.

"TMS is a well-tolerated, non-invasive treatment for depression that is offered in-office. TMS uses a MRI-strength magnetic coil to deliver a low-energy pulse to a targeted area of the brain, and is delivered consistently for four to six weeks to the patient, and then maintenance treatments are given as needed. Results are typically seen within the first two to three weeks," explained Steve Levine, M.D., internationally recognized interventional psychiatrist and Chief Medical Officer with Actify.

"At Actify, we want to give back to veterans who have done their part for others. Now, it's our turn to do our part for them," said Kathy Kaluhiokalani, Actify's CEO. "We are enthusiastic to offer convenient insurance coverage through TRICARE East in both our Baltimore and Potomac offices. We look forward to educating Veterans about Actify and their mental healthcare treatment options, such as TMS."

For more information on Actify, TMS, and other depression treatments, please visit www.ActifyNeuro.com

About Actify

Actify offers innovative treatments for depression and other mental healthcare disorders, including ketamine infusion therapy, Spravato (esketamine) and TMS, and is a leading national provider of mental health treatment with multiple centers in eight states across the country. Our board certified psychiatrists and PMHNPs have treated thousands of patients since 2011 using industry leading methods and technology to achieve optimal results. The company is headquartered in Princeton, NJ and backed by Anthos Capital.

SOURCE Actify


These press releases may also interest you

at 02:59
Immunovia's new lab staffed and operational after rapid implementation
Immunovia (STOCKHOLM: IMMNOV), the diagnostics company seeking to increase pancreatic cancer survival through early detection, today offers an update on its new lab in Research Triangle Park, USA.  Immunovia announced on 29 April the company's...

at 02:23
Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout
Sobi® today announced the initiation of a rolling Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for SEL-212. The submission is based on the results of the DISSOLVE I and II pivotal studies. SEL-212 is an...

at 02:00
Menarini's cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw
Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the potential for an automated system to deliver genomic profiles of fetal cells that is highly concordant with the genomic analysis obtained from...

at 01:35
4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth
4Moving Biotech (4MB), a clinical-stage subsidiary of 4P-Pharma specializing in immuno-inflammation and osteoarthritis, is pleased to announce the appointment of Luc Boblet as Chief Executive Officer. The company, having successfully completed its...

at 01:00
Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroendocrine tumors based on positive CABINET Phase III trial
 Decision adds to existing collaboration agreement with Exelixis, permitting Ipsen to seek potential marketing authorizations for Cabometyx® (cabozantinib) in advanced pancreatic and extra pancreatic neuroendocrine tumors outside of the U.S. and...

at 01:00
The Bradford Exchange Mint Honors the New Princess of Wales
Beautiful, charming, and caring, Catherine Middleton seemed born to be a princess. She met Prince William at university, and their fairy-tale romance of prince and commoner captured the hearts of millions. Married at Westminster Abbey on 29 April...

More news about Health...


News published on and distributed by: